Susan Dorman to HIV-1
This is a "connection" page, showing publications Susan Dorman has written about HIV-1.
Connection Strength
0.329
-
Efavirenz Pharmacokinetics and Human Immunodeficiency Virus Type 1 (HIV-1) Viral Suppression Among Patients Receiving Tuberculosis Treatment Containing Daily High-Dose Rifapentine. Clin Infect Dis. 2022 09 10; 75(4):560-566.
Score: 0.187
-
Diagnosis of HIV-associated tuberculosis. Curr Opin HIV AIDS. 2018 11; 13(6):462-468.
Score: 0.143